[HTML][HTML] Gleason grading and prognostic factors in carcinoma of the prostate
PA Humphrey - Modern pathology, 2004 - Elsevier
Gleason grade of adenocarcinoma of the prostate is an established prognostic indicator that
has stood the test of time. The Gleason grading method was devised in the 1960s and …
has stood the test of time. The Gleason grading method was devised in the 1960s and …
[HTML][HTML] Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer
RL Bitting, AJ Armstrong - Endocrine-related cancer, 2013 - erc.bioscientifica.com
Prostate and breast cancer are the two cancers with the highest incidence in men and
women, respectively. Here, we focus on the known biology of acquired resistance to …
women, respectively. Here, we focus on the known biology of acquired resistance to …
Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology
JL Mohler, ES Antonarakis, AJ Armstrong… - Journal of the National …, 2019 - jnccn.org
The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis,
risk stratification and workup, treatment options for localized disease, and management of …
risk stratification and workup, treatment options for localized disease, and management of …
Prostate cancer risk stratification via nondestructive 3D pathology with deep learning–assisted gland analysis
Prostate cancer treatment planning is largely dependent upon examination of core-needle
biopsies. The microscopic architecture of the prostate glands forms the basis for prognostic …
biopsies. The microscopic architecture of the prostate glands forms the basis for prognostic …
Predicting 15-year prostate cancer specific mortality after radical prostatectomy
Purpose: Long-term prostate cancer specific mortality after radical prostatectomy is poorly
defined in the era of widespread screening. An understanding of the treated natural history …
defined in the era of widespread screening. An understanding of the treated natural history …
World Health Organization classification of tumours: Pathology & genetics of tumours of the urinary system and male genital organs
TY Chan - Urology, 2005 - goldjournal.net
This 2004 volume in the World Health Organization series on histologic and genetic typing
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …
of human tumors covers tumors of the kidney, urinary system, prostate, testis and …
68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
F Ceci, C Uprimny, B Nilica, L Geraldo… - European journal of …, 2015 - Springer
Purpose To assess the association between PSA levels, PSA kinetics and other factors and
a pathological 68 Ga-PSMA PET/CT scan in patients with recurrent prostate cancer (rPCa) …
a pathological 68 Ga-PSMA PET/CT scan in patients with recurrent prostate cancer (rPCa) …
The CAPRA‐S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy
MR Cooperberg, JF Hilton, PR Carroll - Cancer, 2011 - Wiley Online Library
BACKGROUND: The authors previously developed and validated the Cancer of the Prostate
Risk Assessment (CAPRA) score to predict prostate cancer recurrence based on …
Risk Assessment (CAPRA) score to predict prostate cancer recurrence based on …
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal …
Background Adjuvant imatinib mesylate prolongs recurrence-free survival (RFS) after
resection of localised primary gastrointestinal stromal tumours (GIST). We aimed to develop …
resection of localised primary gastrointestinal stromal tumours (GIST). We aimed to develop …
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian …
Abstract Background: Updated National Academy of Clinical Biochemistry (NACB)
Laboratory Medicine Practice Guidelines for the use of tumor markers in the clinic have been …
Laboratory Medicine Practice Guidelines for the use of tumor markers in the clinic have been …